M
Maicon Falavigna
Researcher at Universidade Federal do Rio Grande do Sul
Publications - 108
Citations - 6354
Maicon Falavigna is an academic researcher from Universidade Federal do Rio Grande do Sul. The author has contributed to research in topics: Medicine & Randomized controlled trial. The author has an hindex of 27, co-authored 89 publications receiving 4227 citations. Previous affiliations of Maicon Falavigna include McMaster University & Pontifícia Universidade Católica do Rio Grande do Sul.
Papers
More filters
Posted ContentDOI
Hydroxychloroquine alone or in combination with azithromycin to prevent major clinical events in hospitalised patients with coronavirus infection (COVID-19): rationale and design of a randomised, controlled clinical trial
Alexandre Biasi Cavalcanti,Fernando G. Zampieri,Lcp Azevedo,Regis Goulart Rosa,Alvaro Avezum,Viviane C Veiga,Renato D. Lopes,Leticia Kawano-Dourado,Lucas P. Damiani,Pereira Aj,Serpa Neto A,Remo H.M. Furtado,Bruno Martins Tomazini,Fernando A. Bozza,Israel Silva Maia,Maicon Falavigna,Thiago Lisboa,Fonseca H,Flávia Ribeiro Machado,Berwanger O +19 more
TL;DR: Hydroxychloroquine and its combination with azithromycin have been suggested to improve viral clearance in patients with COVID-19, but its effect on clinical outcomes remains uncertain.
Journal ArticleDOI
Prevalence of papillomavirus in Brazil: a systematic review protocol
Verônica Colpani,Augusto Bacelo Bidinotto,Maicon Falavigna,Silvana Pereira Giozza,Adele Schwartz Benzaken,Cristina Pimenta,Ana Goretti Kalume Maranhão,Carla Magda Allan Santos Domingues,Luciano Serpa Hammes,Eliana Marcia Wendland +9 more
TL;DR: The prevalence of perineal and oral HPV infection in the general population as well as the prevalence of HPV infections in individuals with premalignant and malignant lesions in Brazil and its 5 geographic regions are estimated.
Journal ArticleDOI
Applying evidence-based methods to the development and use of adverse outcome pathways
Rob de Vries,Rob de Vries,Michelle M. Angrish,Patience Browne,Jan Brozek,Andrew A. Rooney,Daniele Wikoff,Paul Whaley,Paul Whaley,Stephen W. Edwards,Rebecca L. Morgan,Ingrid L. Druwe,Sebastian Hoffmann,Thomas Hartung,Kristina A. Thayer,Marc T. Avey,Brandiese E. J. Beverly,Maicon Falavigna,Maicon Falavigna,Catherine F. Gibbons,Katy O. Goyak,Andrew D. Kraft,Fernando Kenji Nampo,Amir Qaseem,Meg Sears,Jasvinder A. Singh,Catherine Willett,Erin Y Yost,Holger J. Schünemann,Katya Tsaioun +29 more
TL;DR: The group concluded that adverse outcome pathways provide an important framework to support mechanism-based assessment in environmental health and was suggested to explore the details of applying systematic methods to adverse outcome pathway development in a series of case studies and workshops.
Journal ArticleDOI
Isosorbide and nifedipine for Chagas' megaesophagus: A systematic review and meta-analysis.
Celina Borges Migliavaca,Cinara Stein,Verônica Colpani,Sandro René Pinto de Sousa Miguel,Luciane Nascimento Cruz,Roberto Oliveira Dantas,Maicon Falavigna,Maicon Falavigna +7 more
TL;DR: Although limited, available evidence shows that both isosorbide and nifedipine are effective in reducing esophageal symptoms.
Journal ArticleDOI
Effectiveness of pharmaceutical care at discharge in the emergency department: study protocol of a randomized controlled trial.
Regina Kuhmmer,Karine Margarites Lima,Rodrigo Antonini Ribeiro,Luciano Serpa Hammes,Gisele Alsina Nader Bastos,Maria Claudia Schardosim Cotta de Souza,Carisi Anne Polanczyk,Guilherme Alcides Flores Soares Rollin,Suhelen Caon,Cátia Moreira Guterres,Leni Everson Araújo Leite,Tássia Scholante Delabary,Maicon Falavigna,Maicon Falavigna +13 more
TL;DR: The hypothesis is that pharmaceutical counseling is also effective in patients discharged from emergency departments in patients with hypertension and/or diabetes, as well as feasible and effective in increasing medication adherence in both hospital outpatient and community pharmacy settings.